Champlain Investment Partners LLC Makes New Investment in Phreesia, Inc. (NYSE:PHR)

Champlain Investment Partners LLC purchased a new position in Phreesia, Inc. (NYSE:PHR) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,251,200 shares of the company’s stock, valued at approximately $29,941,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in PHR. International Assets Investment Management LLC raised its holdings in shares of Phreesia by 1,987.3% during the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after acquiring an additional 1,411 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in shares of Phreesia by 5,462.3% during the 4th quarter. Russell Investments Group Ltd. now owns 3,838 shares of the company’s stock worth $89,000 after acquiring an additional 3,769 shares in the last quarter. Raymond James & Associates purchased a new stake in shares of Phreesia during the 4th quarter worth approximately $226,000. ProShare Advisors LLC raised its holdings in shares of Phreesia by 8.6% during the 1st quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock worth $228,000 after acquiring an additional 751 shares in the last quarter. Finally, Trust Point Inc. purchased a new stake in shares of Phreesia during the 4th quarter worth approximately $239,000. 92.10% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Chaim Indig sold 2,644 shares of the business’s stock in a transaction dated Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total transaction of $62,768.56. Following the sale, the chief executive officer now owns 1,219,361 shares in the company, valued at $28,947,630.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Chaim Indig sold 2,644 shares of the business’s stock in a transaction dated Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total transaction of $62,768.56. Following the sale, the chief executive officer now owns 1,219,361 shares in the company, valued at $28,947,630.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark Douglas Smith sold 7,000 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $25.00, for a total value of $175,000.00. Following the sale, the director now owns 30,653 shares in the company, valued at approximately $766,325. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,506 shares of company stock worth $375,299. 5.80% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on PHR. Canaccord Genuity Group decreased their price objective on Phreesia from $37.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 31st. KeyCorp decreased their price target on Phreesia from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, July 11th. Stephens restated an “overweight” rating and set a $28.00 price target on shares of Phreesia in a report on Friday, May 31st. Truist Financial restated a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Monday, July 1st. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a report on Friday, May 31st. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $30.54.

Phreesia Stock Up 1.7 %

Phreesia stock traded up $0.41 during trading hours on Tuesday, reaching $24.02. The stock had a trading volume of 302,374 shares, compared to its average volume of 492,821. The company has a market cap of $1.38 billion, a price-to-earnings ratio of -10.88 and a beta of 0.93. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.76 and a quick ratio of 1.76. The business’s 50 day moving average price is $21.24 and its 200-day moving average price is $23.08. Phreesia, Inc. has a 52 week low of $12.05 and a 52 week high of $32.11.

Phreesia (NYSE:PHR) last announced its earnings results on Thursday, May 30th. The company reported ($0.35) EPS for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.16. The business had revenue of $101.20 million during the quarter, compared to the consensus estimate of $100.94 million. Phreesia had a negative net margin of 31.87% and a negative return on equity of 46.89%. The firm’s revenue was up 20.8% on a year-over-year basis. During the same period in the previous year, the company posted ($0.70) earnings per share. Sell-side analysts anticipate that Phreesia, Inc. will post -1.16 EPS for the current year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.